Co-Diagnostics, Inc.

General ticker "CODX" information:

  • Sector: Health Care
  • Industry: Medical - Devices
  • Capitalization: $9.7M (TTM average)

Co-Diagnostics, Inc. does not follow the US Stock Market performance with the rate: -10.7%.

Estimated limits based on current volatility of 57.9%: low 5.28$, high 9.43$

Factors to consider:

  • Total employees count: 155 (+6.9%) as of 2023
  • US accounted for 72.1% of revenue in the fiscal year ended 2022-12-31
  • Top business risk factors: Regulatory and compliance, Product development delays, Cybersecurity threats, Labor/talent shortage/retention, Operational and conduct risks
  • Earnings for 3 months up through Q1 are below our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2025-12-31 to 2027-12-31

  • 2025-12-31 to 2026-12-31 estimated range: [5.32$, 14.25$]
  • 2026-12-31 to 2027-12-31 estimated range: [3.81$, 10.66$]

Financial Metrics affecting the CODX estimates:

  • Negative: with PPE of -0.3 at the end of fiscal year the price was high
  • Negative: negative Operating cash flow
  • Negative: negative Operating income
  • Positive: Investing cash flow per share per price, % of 279.09 > -0.60
  • Negative: negative Net income
  • Positive: Industry inventory ratio change (median), % of -0.30 <= -0.16

Similar symbols

Short-term CODX quotes

Long-term CODX plot with estimates

Financial data

YTD 2024-12-31 2025-12-31
Operating Revenue $3.92MM $0.62MM
Operating Expenses $44.00MM $50.79MM
Operating Income $-40.08MM $-50.17MM
Non-Operating Income $2.50MM $1.65MM
R&D Expense $20.98MM $19.14MM
Income(Loss) $-37.58MM $-48.51MM
Taxes $0.06MM $-1.62MM
Net Income(Loss)* $-37.64MM $-46.90MM
Stockholders Equity $54.31MM $20.63MM
Inventory $1.07MM $0.99MM
Assets $64.00MM $24.74MM
Operating Cash Flow $-29.16MM $-29.14MM
Capital expenditure $0.75MM $0.70MM
Investing Cash Flow $17.07MM $26.27MM
Financing Cash Flow $0.10MM $11.81MM
Earnings Per Share** $-37.22 $-35.25

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.